ArticleBlood vessels, thrombosis & hemostasis2026
Abnormal whole-blood viscoelastic test results in patients with bleeding disorder of unknown cause.
Article in Blood vessels, thrombosis & hemostasis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bleeding disorder of unknown cause (BDUC) is a diagnosis of exclusion in patients with a clinically relevant bleeding tendency. Although patients with BDUC often display bleeding phenotypes similar to those with other established mild-to-moderate bleeding disorders, global assays to identify BDUC or predict bleeding severity are lacking. Diagnostic utility of nonactivated rotational thromboelastometry (ROTEM) in patients with BDUC and its association with bleeding severity and risk of future bleeding were assessed. In total, 464 patients with BDUC from the Vienna Bleeding Biobank were compared with 100 age-matched healthy controls. ROTEM was performed within 1 hour of sampling. The assessed parameters included clotting time (CT), clot formation time, maximum clot firmness, maximal lysis (ML), and area under the curve (AUC). Overall, we observed a delayed clot formation process with reduced lysis potential resulting in a larger ROTEM-AUC in patients with BDUC. Compared with controls, patients with BDUC exhibited prolonged CT (median, 634.0 vs 617.5 s;
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.